Detailed Images Reveal Interactions That Affect Signaling in the Brain
Never-before seen snapshots of brain receptor may aid in design of targeted therapeutics for variety of neurological and psychiatric disorders
Scientists at Columbia University have obtained the first detailed images of interactions between the AMPA receptor and molecules that regulate chemical signaling in the brain. Their findings may help understand the processes that contribute to conditions such as Alzheimer’s and Parkinson’s diseases, epilepsy, and schizophrenia—and could lead to the development of drugs to counteract these conditions. AMPA receptors respond to the release of chemical signals in the brain, which in turn governs brain function. Dysfunction in AMPA receptor signaling has been associated with a variety of neurological disorders. But because AMPA receptors are distributed throughout the brain, drugs aimed at modifying AMPA receptor activity have the potential to cause numerous severe side effects.
Click here to read more.
International Conference on Dual Diagnosis and Disorders
Nov. 14-15, 2018; Melbourne, Austrailia
Microsurgical Approaches to Aneurysms and Skull Base Diseases 2018
Nov. 15-17, 2018; Jacksonville, Fla.
2018 Mayo Clinic Multidisciplinary Spine Care Conference
Nov. 16-17, 2018; Amelia Island, Fla.
Craniofacial Surgery and Transfacial Approaches to the Skull Base
Nov. 30-Dec. 2, 2018; St. Louis
Comprehensive Endoscopic Endonasal Surgery of the Skull Base Course
Dec. 5-8, 2018; Pittsburgh